Impact of patient demographics on treatment outcomes in AML: a population-based registry in England, 2013-2020
(2024)
Journal Article
Liu, H., Stanworth, S. J., McPhail, S., Bishton, M., Rous, B., Bacon, A., & Coats, T. (2024). Impact of patient demographics on treatment outcomes in AML: a population-based registry in England, 2013-2020. Blood Advances, 8(17), 4593-4605. https://doi.org/10.1182/bloodadvances.2024013102
We report 1- and 5-year survival following AML diagnosis and early mortality, within 30 days of systemic anti-cancer therapy (SACT) treatments, using national cancer registry data in England.
Patients aged 18-99 years diagnosed between 2013 and 2...
Read More about Impact of patient demographics on treatment outcomes in AML: a population-based registry in England, 2013-2020.